Solitary plasmacytoma DC 7724
VA rates it under diagnostic code 7724 in 38 CFR 4.117. Body system: Other.
How VA rates it
The schedule has one rating level for this code: 100%.
Source: 38 CFR 4.117 on eCFR. Read the full criteria there before you file.
Rating levels and criteria
| Rating | What the schedule says |
|---|---|
| 100% | Solitary plasmacytoma, when there is active disease or during a treatment phase |
Criteria text from 38 CFR 4.117, eCFR as of November 10, 2026. The eCFR is the official source if anything here differs.
Notes in the schedule (3)
Note (1): A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures (including autologous stem cell transplantation). Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate residuals under the appropriate diagnostic codes
Note (2): Rate a solitary plasmacytoma that has developed into multiple myeloma as symptomatic multiple myeloma
Note (3): Rate residuals of plasma cell dysplasia (e.g., thrombosis) and adverse effects of medical treatment (e.g., neuropathy) under the appropriate diagnostic codes
Check your claim
The claim finder asks about your service and current ratings, then lists conditions you may be able to claim. The calculator shows what a new rating does to your combined rating and monthly pay.
Open the claim finderOpen the VA rating calculator
Free help: an accredited VSO representative can file and track your claim at no cost. Find one near you by ZIP code.
Rating schedule data as of November 10, 2026. Secondary and presumptive links checked November 13, 2026.
Not affiliated with the VA. VA decides ratings. Free help from an accredited VSO is available at no cost.